Schonfeld Strategic Advisors LLC Surface Oncology, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $76,320 - $146,304	-28,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $66,693 - $111,390	14,100 Added 95.92%	28,800 $138,000
Q3 2021 Nov 16, 2021	BUY	$5.16 - $7.98 $75,852 - $117,306	14,700 New	14,700 $112,000
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $312,966 - $441,064	-48,522 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.25 - $13.82 $106,908 - $203,789	-14,746 Reduced 23.31%	48,522 $378,000
Q4 2020 Feb 16, 2021	SELL	$6.87 - $10.48 $266,775 - $406,959	-38,832 Reduced 38.03%	63,268 $585,000
Q3 2020 Nov 16, 2020	BUY	$5.06 - $7.23 $149,270 - $213,285	29,500 Added 40.63%	102,100 $1,000
Q2 2020 Aug 14, 2020	BUY	$1.57 - $6.56 $113,982 - $476,256	72,600 New	72,600 $476,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.